Type
Internal restructuring
Country
Italy
Region
Isole; Sicilia; Catania
Location of affected unit(s)
Catania
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21.1 - Manufacture of basic pharmaceutical products
21.1 - Manufacture of basic pharmaceutical products

370 jobs
Number of planned job losses
Job loss
Announcement Date
7 July 2026
Employment effect (start)
Foreseen end date

Description

Pfizer, a multinational pharmaceutical company, has announced approximately 370 job cuts (330 direct employees and 40 agency workers) at its production plant in Catania, Italy.

The restructuring follows a downsizing plan affecting the local manufacturing site, including the earlier closure of the penicillin department.

The job reductions are expected to involve direct dismissals of permanent staff as well as the non-renewal of temporary agency contracts, while potential indirect effects on subcontractors and service providers may also arise.

Trade unions (Filctem CGIL, Femca CISL, Uiltec UIL, UGL Chimici and CISAL) have reacted by announcing a programme of industrial action, including strikes and protests, requesting the resignation of the site director and calling for government intervention, while also criticising both company management and the limited response from local institutions.


Citation

Eurofound (2026), Pfizer, Internal restructuring in Italy, factsheet number 300721, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/300721.